Skip to main content
. 2018 Feb 14;2(1):e68–e88. doi: 10.1055/s-0038-1624566

Fig. 4.

Fig. 4

Specificity of imatinib, dasatinib, nilotinib, and ponatinib toward tyrosine kinases. Green, yellow, red, and blue circles contain tyrosine kinase inhibited by dasatinib, nilotinib, bosutinib, and ponatinib, respectively. Tyrosine kinases in white represent imatinib off-targets. This figure summarizes results from 13 experiments. 39 43 130 132 133 134 135 136 137 156 157 158 159 In case of conflictual results between studies, a conservative approach has been applied. Additional information is provided in the Supplementary Material .